Filter
6294
Filtered Results: 6294
Text search:
drug
use
Featured
Recommendations
542
New Publications
1636
Language
Document type
No document type
3872
Studies & Reports
906
Guidelines
779
Manuals
255
Strategic & Response Plan
164
Fact sheets
128
Training Material
84
Infographics
29
Situation Updates
28
Resource Platforms
19
Brochures
16
Online Courses
10
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
384
Kenya
186
Global
184
South Africa
151
Ethiopia
139
Western and Central Europe
139
Uganda
133
Nigeria
120
Nepal
114
Tanzania
100
Sierra Leone
97
Liberia
97
Malawi
94
Zambia
90
Africa
86
Myanmar / Burma
85
Bangladesh
79
Latin America and the Carribbean
78
Ghana
77
Ukraine
74
Eastern Europe
72
Rwanda
69
Philippines
55
Namibia
55
Russia
55
Zimbabwe
48
Asia
44
South–East Asia Region
41
Cambodia
40
Lesotho
38
Indonesia
37
Congo, Democratic Republic of
31
Brazil
31
Syria
30
Botswana
30
Mozambique
29
Senegal
26
Eswatini/ Swaziland
25
Germany
23
East and Southern Africa
23
Burkina Faso
21
West and Central Africa
21
Middle East and North Africa
21
Colombia
20
USA
18
South Sudan
18
Eastern Europe and Central Asia
17
Cameroon
16
Haiti
16
Venezuela
15
Tajikistan
15
Albania
14
Guinea
12
Pakistan
12
Vietnam
12
Thailand
11
Georgia
11
Afghanistan
10
Argentina
10
Peru
10
Moldova
10
China
9
Sudan
9
Benin
9
Paraguay
9
Armenia
8
Chile
7
Yemen
7
Laos
7
North Macedonia
6
Bolivia
6
Mexico
6
Western Pacific Region
6
Mali
5
Somalia
5
Iraq
5
Jordan
5
Lebanon
5
Central African Republic
5
Ecuador
5
El Salvador
5
Sri Lanka
5
Spain
5
Turkey
4
Papua New Guinea
4
Libya
4
Angola
4
Bhutan
4
Southern Africa
4
Estonia
4
Jamaica
4
United Kingdom
4
Guinea-Bissau
3
Switzerland
3
Madagascar
3
Fiji
3
Palestine
3
Timor Leste/ East Timor
3
Iran
3
Uzbekistan
3
Kyrgyzstan
3
North America
3
Uruguay
3
Belarus
3
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Serbia
2
Hungary
2
Honduras
2
Poland
2
Mongolia
2
Canada
2
Romania
2
Kazakhstan
2
Gabon
2
Turkmenistan
2
Belgium
2
France
2
Tunisia
2
Portugal
2
Niger
1
Egypt
1
Chad
1
Gambia
1
Malaysia
1
Ireland
1
Singapore
1
Austria
1
Greece
1
Guatemala
1
Nicaragua
1
Solomon Islands
1
North Korea
1
Italy
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Lithuania
1
Australia
1
Denmark
1
Maldives
1
Mauritius
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
2392
Clinical Guidelines
565
Public Health
292
Women & Child Health
235
Key Resources
116
Capacity Building
95
Pharmacy & Technologies
72
Annual Report MEDBOX
1
Toolboxes
HIV
742
Mental Health
687
TB
608
AMR
320
COVID-19
311
Pharmacy
206
NTDs
195
NCDs
150
Caregiver
120
Rapid Response
103
Ebola
98
Refugee
86
Planetary Health
80
Disability
70
Conflict
67
Global Health Education
55
Health Financing Toolbox
37
Polio
24
Natural Hazards
24
Specific Hazards
22
Cholera
21
Zika
21
Social Ethics
18
Health Financing
1
The updated List of Essential Diagnostics contains 46 general tests that can be used for routine patient care as well as for the detection and diagnosis of a wide array of disease conditions, and 69 tests intended for the detection, diagnosis and mo...
Social network-based HIV testing is an approach for engaging sexual and drug injecting partners and social contacts of key population members with HIV and of those who are HIV-negative and at ongoing risk in voluntary HTS.
By addressing people’...
This guideline covers making people aware of how to correctly use antimicrobial medicines (including antibiotics) and the dangers associated with their overuse and misuse. It also includesmeasures to prevent and control infection that can stop peopl...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with ...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty ...
The purpose of these guidelines is to give practical advice to doctors so that all services and models of care used by doctors and health workers are encouraged to consider the use of telemedicine a...
This third regional report discusses gaps and challenges in reducing the harmful use of alcohol and how countries can reverse current trends in a cost-effective and expedited way.
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of...
The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for
surveillance and response. This framework serves as an outline to guide stakeholders interested in implementing
event-based surveillance (E...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced C...
Quality Assurance (QA) and Quality Improvement (QI). The guide provides general information on how to organize, implement and follow up on quality assurance/quality improvement clinical facility and service assessments. At the website you will find checklists intended to be ...d with the clinical facility assessment guide
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence ...
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affordability, geographical accessibility, quality and r...
This Situation Update describes events occurring in Bilin Township, Thaton District during the period between July and October 2017, including healthcare, education, development projects and drug issues.
Module: Disorders due to substance abuse mhGAP
recommended
Accessed: 21.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248
In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientific knowledge pe...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a ...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International ... Monitoring. This text was developed in consultation with the WHO Collaborating Centre for International Drug Monitoring and the national pharmacovigilance centres participating in the WHO Programme for International Drug Monitoring.
